A Multi-Center Study of MYOBLOC for the Treatment of Sialorrhea in Parkinson's Disease Patients
Public ClinicalTrials.gov record NCT00515437. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multi-Center, Randomized, Double-blind, Placebo-Controlled,Sequential Dose Escalation, Safety, Tolerability, and Preliminary Efficacy Study of MYOBLOC for the Treatment of Sialorrhea in Parkinson's Disease Patients
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
To determine safety, tolerability and preliminary efficacy of intraglandular injections of MYOBLOC for the treatment of sialorrhea in Parkinsons' Disease patients
Study identification
- NCT ID
- NCT00515437
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 54 participants
Conditions and interventions
Conditions
Interventions
- Botulinum Toxin Type B (Myobloc) Biological
- Matched placebo to Myobloc Biological
Biological
Eligibility (public fields only)
- Age range
- 18 Years to 85 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 2007 (Type not available)
- Primary completion
- Jun 2008 (Actual)
- Completion
- Sep 2008 (Actual)
- Last update posted
- Apr 21, 2026
2007 – 2008
United States locations
- U.S. sites
- 18
- U.S. states
- 17
- U.S. cities
- 18
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Dr Virgilio Evidente | Scottsdale | Arizona | 85259 | — |
| Dr. Ronald Ziman | Northridge | California | 91325 | — |
| Dr. James Sutton | Oxnard | California | 93030 | — |
| Dr. Olga Klepitskaya | Denver | Colorado | 80262 | — |
| Dr. Fernando Pagan | Washington D.C. | District of Columbia | 20007 | — |
| Dr Hubert Fernandez | Gainesville | Florida | 32610 | — |
| Dr. Alan Freeman | Atlanta | Georgia | 30329 | — |
| Dr. Katie Kompoliti | Chicago | Illinois | 60612 | — |
| Dr. Robert Rodnitzky | Iowa City | Iowa | 52242 | — |
| Dr. Stephen Reich | Baltimore | Maryland | 21201 | — |
| Dr. Brad Racette | St Louis | Missouri | 63110 | — |
| Dr. Eric Molho | Albany | New York | 12205 | — |
| Dr. Joseph Friedman | Warwick | Rhode Island | 02886 | — |
| Dr. Vanessa Hinson | Charleston | South Carolina | 29401 | — |
| Dr. Sam Kabbani | Knoxville | Tennessee | 37923 | — |
| Dr. Madhavi Thomas | Dallas | Texas | 75231 | — |
| Dr. Gordon Smith | Salt Lake City | Utah | 84132 | — |
| Dr. Patrick Hogan | Tacoma | Washington | 98405 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00515437, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 21, 2026 · Synced Oct 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00515437 live on ClinicalTrials.gov.